4th International Symposium on Biopharmaceutical Innovation

Why you should attend?

Listening to successful experience of regulatory registration from global and China’s biopharmaceuticals

Learning antibody & protein structure design and optimization for early discovery under computer to achieve drug di erentiation strategy

Exploring international leading protein and antibody engineering technology and innovational application

Improving the eciency of biopharmaceuticals’ druggability selection and assessment, to guide clinical trial design

Following up the updated R&D progress of new structural antibody, and protein under di erent indications

Who should attend?

Biopharmaceutical Regulators